Page 138 - Pagetit
P. 138

4. PSYCHOPHARMACOLOGY OF DEPENDENCE FOR DIFFERENT DRUG CLASSES



                     Kosten TR et al. (2002) Human therapeutic cocaine vaccine: safety and
                     immunogenicity. Vaccine, 20:1196–1204.
                     Krambeer LL et al. (2001) Methadone therapy for opioid dependence. American
                     Family Physician, 15:2404–2410.
                     Kranzler HR (2000) Pharmacotherapy of alcoholism: gaps in knowledge and
                     opportunities for research. Alcohol and Alcoholism, 35:537–547.
                     Krausz M (2002) Modellprojekt: heroin als medicament [Model project: heroin
                     as medication]. Deutsches Ärzteblatt, 99:A26–A28.
                     Kreek MJ (2000) Methadone-related opioid agonist pharmacotherapy for heroin
                     addiction: history, recent molecular and neurochemical research and future in
                     mainstream medicine. Annals of the New York Academy of Sciences, 909: 186-216.
                     Kuczenski R, Segal DS (1992) Differential effects of amphetamine and dopamine
                     uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate
                     dopamine and 3-methoxytyramine. Journal of Pharmacology and Experimental
                     Therapeutics, 262:1085–1094.
                     Kuhar MJ et al. (2001) Anticocaine catalytic antibodies have no affinity for RTI
                     compounds: implications for treatment. Synapse, 41:176–178.
                     Lahti AC et al. (1995) Ketamine activates psychosis and alters limbic blood flow
                     in schizophrenia. Neuroreport, 6:869–782.
                     Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proceedings of the
                     Association of American Physicians, 111:99–108.
                     Ling W et al. (1998) Buprenorphine maintenance treatment of opiate dependence:
                     a multicenter, randomized clinical trial. Addiction, 93:475–486.
                     Lodge D, Johnson KM (1990) Noncompetitive excitatory amino acid receptor
                     antagonists. Trends in Pharmacological Sciences, 11:81–86.
                     Luisada PV (1978) The phencyclidine psychosis: phenomenology and treatment.
                     NIDA Research Monograph, 21:241–253.
                     Lukas RJ et al. (1999) Current status of the nomenclature for nicotinic
                     acetylcholine receptors and their subunits. Pharmacological Reviews, 51:397–401.
                     McBride WJ (2002) Central nucleus of the amygdala and the effects of alcohol
                     and alcohol-drinking behavior in rodents. Pharmacology, Biochemistry and
                     Behavior, 71:509–515.

                     McBride WJ, Li TK (1998) Animal models of alcoholism: neurobiology of high
                     alcohol-drinking behavior in rodents. Critical Reviews in Neurobiology, 12:339–
                     369.
                     McCance-Katz EF, Kosten TR, Jatlow P (1998) Concurrent use of cocaine and
                     alcohol is more potent and potentially more toxic than use of either alone: a
                     multiple-dose study. Biological Psychiatry, 44:250–259.
                     McCann U, Ricaurte G (1991) Lasting neuropsychiatric sequelae of
                     methylenedioxymethamphetamine (“ecstasy”) in recreational users. Journal of
                     Clinical Psychopharmacology, 11:302–305.
                     Maccarrone M et al. (1998) Anandamide hydrolysis by human cells in culture
                     and brain. Journal of Biological Chemistry, 273:32 332–32 339.


                                                     117




          Chapter_4                117                             19.1.2004, 11:44
   133   134   135   136   137   138   139   140   141   142   143